When to Use Initial Triple Therapy in COPD: Adding a LAMA to ICS/LABA by Clinically Important Deterioration Assessment

PURPOSE: Triple therapy versus dual therapy for chronic pulmonary obstructive disease (COPD) can reduce symptoms, limit the risk of acute exacerbations (AEs) as well as improve lung function. Currently, studies that feature clinically important deterioration (CID) as a composite endpoint to assess t...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Chron Obstruct Pulmon Dis
Autors principals: Cheng, Wen-Chien, Wu, Biing-Ru, Liao, Wei-Chih, Chen, Chih-Yu, Chen, Wei-Chun, Hsia, Te-Chun, Tu, Chih-Yen, Chen, Chia-Hung, Hsu, Wu-Huei
Format: Artigo
Idioma:Inglês
Publicat: Dove 2020
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7764554/
https://ncbi.nlm.nih.gov/pubmed/33376318
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S279482
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars